Bile Spillage as a Prognostic Factor for Gall Bladder Cancer: A Systematic Review and Meta-Analysis

J Surg Res. 2024 Jul:299:94-102. doi: 10.1016/j.jss.2024.04.004. Epub 2024 May 7.

Abstract

Introduction: Biliary spillage (BS) is a common complication following initial cholecystectomy for gall bladder cancer (GBC). Few studies have explored the importance of BS as a long-term prognostic factor. We perform a meta-analysis of the association between BS and survival in GBC.

Methods: A systematic literature search was performed in February 2023. Studies evaluating the incidence of BS and its association with long-term outcomes in patients undergoing initial laparoscopic or open cholecystectomy for either incidental or resectable GBC were included. Overall survival (OS), disease-free survival (DFS), and rate of peritoneal carcinomatosis (RPC) were the primary end points. Forest plot analyses were used to calculate the pooled hazard ratios (HRs) of OS, DFS, and RPC. Metaregression was used to evaluate study-level association between BS and perioperative risk factors.

Results: Of 181 published articles, 11 met inclusion criteria with a sample size of 1116 patients. The rate of BS ranged between 9% and 67%. On pooled analysis, BS was associated with worse OS (HR = 1.68, 95% confidence interval [CI] = 1.32-2.14), DFS (pooled HR= 2.19, 95% CI = 1.30-3.68), and higher RPC (odds ratio = 9.37, 95% CI = 3.49-25.2). The rate of BS was not associated with higher T stage, lymph node metastasis, higher grade, positive margin status, reresection, or conversion rates.

Conclusions: Our meta-analysis shows that BS is a predictor of higher peritoneal recurrence and poor survival in GBC. BS was not associated with tumor characteristics or conversion rates. Further research is needed to identify other potential risk factors for BS and investigate the ideal treatment schedule to improve survival.

Keywords: Bile spillage; Gall bladder cancer; Survival.

Publication types

  • Systematic Review
  • Meta-Analysis
  • Review

MeSH terms

  • Bile
  • Cholecystectomy / adverse effects
  • Disease-Free Survival
  • Gallbladder Neoplasms* / diagnosis
  • Gallbladder Neoplasms* / mortality
  • Gallbladder Neoplasms* / pathology
  • Gallbladder Neoplasms* / surgery
  • Humans
  • Peritoneal Neoplasms / diagnosis
  • Peritoneal Neoplasms / epidemiology
  • Peritoneal Neoplasms / mortality
  • Peritoneal Neoplasms / secondary
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Postoperative Complications / mortality
  • Prognosis
  • Risk Factors